Tocilizumab significantly reduced 28-day mortality and length of ICU stay in patients with severe COVID-19 pneumonia and low S-spike nAb titers.

Powerful llama-derived antibodies could be the key to stopping not just current SARS viruses, but future ones too. Scientists ...

A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization ...

There are nine major allergens, including soybeans, wheat, sesame, milk, eggs, fish, crustacean shellfish, tree nuts and peanuts. For customers with allergies to these allergens, consumption of food ...

People have been warned they could experience a host of unusual symptoms if they contract the latest Covid variant. The ...

As a leader in its category, Sinotau is probably hoping to follow in the footsteps of Hengrui Pharmaceuticals (1276.HK; ...

Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus infections. However, the ongoing evolution of the virus regularly ...

Researchers from David Baker's lab (University of Washington) have designed this antibody from scratch to neutralize a deadly toxin from C. difficile. [Ian Haydon] “Life could not exist without ...

Such antibodies offer protection against a variety ... the pathogens on the World Health Organisation’s global priority list of antibiotic-resistant bacteria, Dr Tan said. Prof Wang added ...